Opinion
Video
Robert Gabbay, MD, PhD, discusses research showing that early intervention with a recent FDA-approved therapy can delay the onset of type 1 diabetes by an average of 2-3 years.
Updated Guidelines Allow Men Who Have Sex With Men to Join National Blood Donor Month Efforts
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Lung Cancer Screening Facilities Least Accessible to American Indian/Alaska Native Patients, Rural Communities
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Later Loss of Ambulation Linked With Better Heart Health in DMD
Early Onset Active IBD Linked to Higher Rates of Psychiatric Disorders, Medication Use